These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Effects of verapamil on tardive dyskinesia and psychosis in schizophrenic patients. Reiter S; Adler L; Angrist B; Peselow E; Rotrosen J J Clin Psychiatry; 1989 Jan; 50(1):26-7. PubMed ID: 2562952 [TBL] [Abstract][Full Text] [Related]
45. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial. Lee JG; Shin BS; Lee YC; Park SW; Kim YH Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029 [TBL] [Abstract][Full Text] [Related]
47. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders. Ganzini L; Casey DE; Hoffman WF; McCall AL Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437 [TBL] [Abstract][Full Text] [Related]
48. Double-blind evaluation of deanol in tardive dyskinesia. Penovich P; Morgan JP; Kerzner B; Karch F; Goldblatt D JAMA; 1978 May; 239(19):1997-8. PubMed ID: 347112 [TBL] [Abstract][Full Text] [Related]
49. A controlled trial of amantadine hydrochloride and neuroleptics in the treatment of tardive dyskinesia. Angus S; Sugars J; Boltezar R; Koskewich S; Schneider NM J Clin Psychopharmacol; 1997 Apr; 17(2):88-91. PubMed ID: 10950469 [TBL] [Abstract][Full Text] [Related]
50. The effect of ceruletide on tardive dyskinesia: a double-blind placebo-controlled study. Matsunaga T; Ohyama S; Takehara S; Kabashima K; Moriyama S; Tsuzuki J; Ikeda H; Suematsu M; Akizuki K; Fujimoto K Prog Neuropsychopharmacol Biol Psychiatry; 1988; 12(4):533-9. PubMed ID: 3043555 [TBL] [Abstract][Full Text] [Related]
51. Oxypertine in tardive dyskinesia: an 8-week controlled study. Soni SD; Freeman HL; Hussein EM Br J Psychiatry; 1984 Jan; 144():48-52. PubMed ID: 6140973 [TBL] [Abstract][Full Text] [Related]
52. Nilvadipine is effective for chronic schizophrenia in a double-blind placebo-controlled study. off. Yamada K; Kanba S; Ashikari I; Ohnishi K; Yagi G; Asai M J Clin Psychopharmacol; 1996 Dec; 16(6):437-9. PubMed ID: 8959468 [TBL] [Abstract][Full Text] [Related]
53. Reserpine and alpha-methyldopa in the treatment of tardive dyskinesia. Huang CC; Wang RI; Hasegawa A; Alverno L Psychopharmacology (Berl); 1981; 73(4):359-62. PubMed ID: 6789358 [TBL] [Abstract][Full Text] [Related]
54. Deanol in the treatment of tardive dyskinesia. Simpson GM; Voitashevsky A; Young MA; Lee JH Psychopharmacology (Berl); 1977 May; 52(3):257-61. PubMed ID: 406628 [TBL] [Abstract][Full Text] [Related]
55. Failure of lithium treatment in established tardive dyskinesia. MacKay AV; Sheppard GP; Saha BK; Motley B; Johnson AL; Marsden CD Psychol Med; 1980 Aug; 10(3):583-7. PubMed ID: 7003639 [TBL] [Abstract][Full Text] [Related]
57. Lithium carbonate in the treatment of tardive dyskinesia. Reda FA; Escobar JI; Scanlan JM Am J Psychiatry; 1975 May; 132(5):560-2. PubMed ID: 804260 [TBL] [Abstract][Full Text] [Related]
58. Serotonin precursor effects in tardive dyskinesia. Nasrallah HA; Smith RE; Dunner FJ; McCalley-Whitters M Psychopharmacology (Berl); 1982; 77(3):234-5. PubMed ID: 6812144 [TBL] [Abstract][Full Text] [Related]
59. Effects of levetiracetam on tardive dyskinesia: a randomized, double-blind, placebo-controlled study. Woods SW; Saksa JR; Baker CB; Cohen SJ; Tek C J Clin Psychiatry; 2008 Apr; 69(4):546-54. PubMed ID: 18312060 [TBL] [Abstract][Full Text] [Related]
60. Double blind controlled trial of deanol in tardive dyskinesia. George J; Pridmore S; Aldous D Aust N Z J Psychiatry; 1981 Mar; 15(1):68-71. PubMed ID: 6942835 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]